Sanofi Belgium’s Post

Here's a little reminder of how important your work is if you work in the pharmaceutical industry. Thanks Robert Snow, CPIP and Chris Heeley for giving me this opportunity and making this happen.

4 Key Takeaways From Eli Lilly’s Earnings

Reflecting on my journey at Sanofi, I've come to appreciate the saying, "Life is lived forward, but understood in reverse." Every step we've taken, every challenge we've faced, and every success we've celebrated has led us to where we are today. It’s only when we look back that the bigger picture becomes clear—how each experience has shaped our path forward. At Sanofi, I’ve realized that our work is about so much more than just innovating healthcare solutions; it’s about building a future that’s deeply connected to the lessons we’ve learned along the way. My experiences here have shown me that every challenge and every success is a stepping stone, informing the decisions I make today and fueling my passion to contribute to something bigger. Here’s to moving forward with intention, learning from the past, and creating a brighter tomorrow. #SanofiStories #GrowthMindset #Career

Cheers to Sanofi innovators! I couldn’t be prouder of our UK and Ireland team as we attended the Global Awards ceremony at La Maison, Sanofi’s headquarters in Paris. Our UK and Ireland team took 2 of the 9 global finalists spots for Thoughtful Risk Taking, among an incredible 847 submissions from all functions worldwide! 🎉 An outstanding Irish project led by Yvonne Preston and Ciaran McKinley and 📈Our groundbreaking work with Hannah Korpez showcasing how AI can diagnose and treat patients faster in the UK. Pharma isn’t typically seen as a fast-moving, innovation-driven industry, and the UK market comes with its own unique challenges including compliance complexities. Yet, these achievements prove that we’re reshaping both the potential and perception of what’s possible! We will of course not stop here. We will keep raising the bar, embracing Thoughtful Risk, and breaking boundaries to bring the miracles of science to patients. 🌟 Rippon Ubhi Rebecca Catterick John Forni Ahmed Moussa Usman Khan #Innovation #HealthcareTransformation #Sanofi

🌟 Celebrating Quality Day at Novo Nordisk 🌟 Today we celebrate #Quality Day at Novo Nordisk, an opportunity to reflect on the importance of quality in everything we do. 🆔 Quality is not just a goal; it is a fundamental part of our identity and guides each of our actions. 💙 Knowing that our commitment to quality had a #positiveimpact on #patients life fills me with pride and motivation to continue giving my best every day. 📝 In fact, this commitment is reflected in one of our core principles: "We never compromise on quality and business ethics." At Novo Nordisk, we believe that quality goes beyond compliance with standards and regulations. It is about driving performance and excellence in all aspects of our organization. This approach allows us not only to meet predefined standards but also to exceed expectations and offer the best to our #patients and #society. We create value by having a patient-centered approach. 👉 Join us in celebrating this day and discover how quality at Novo Nordisk can transform lives and create a healthier future #patientcentricity #qualityday #drivingchange #positiveimpact

Is there such a thing as a flawless launch? Can we truly anticipate and mitigate all potential scenarios despite extensive pre-planning that could sometime span years? How to make the perfect trade-offs? How to achieve quick wins while embracing the concept of failing faster with a mixture of agility, openness, and resilience? My journey has afforded me the opportunity to lead both global and regional launches, offering a diverse array of insights. In this intricate process, crafting a message that resonates with Key Opinion Leaders (KOLs) emphasizing the benefits for patients, serve as the crucial entry point. Incentivizing the core launch team and continuous alignment with secondary and tertiary stakeholders are paramount.

Breaking into pharma isn't easy: ► But Jennifer Wilcox, PhD made it look easy. Jenny just landed her first role in pharma as a Sr. CRA at BeiGene. Her secret? → Staying focused → Building on her strengths → Never losing sight of her goal Jenny, your determination inspires us all. Pharma’s got a new star on the rise! 🎉 Want to start your own journey into pharma? 🔗 Book a demo call with Sarah to learn how Aspire MSL can help you break in! Link below 👇

Eli Lilly and Company created the world’s first GLP-1 medication 20 years ago and continues to innovate with drugs like Zepbound and Mounjaro. In this interview, CEO Dave Ricks explains how they work and what the company’s planning next. "What we're doing is boosting some of those signals with these medications. They're boosting the signal that you're full," Ricks says. "Boosting the signal that you no longer want to eat more and boosting signals that you should absorb nutrients that you've consumed." https://lnkd.in/eeEKTVd8 

#𝗧𝗲𝘃𝗮𝗧𝗵𝗲𝗻𝗔𝗻𝗱𝗡𝗼𝘄: 𝗘𝗺𝗯𝗿𝗮𝗰𝗶𝗻𝗴 𝗗𝗶𝘃𝗲𝗿𝘀𝗶𝘁𝘆 Since the very beginning, Teva took pride in its people and culture, embracing the creativity that comes with different perspectives and dialogue. In today’s rapidly evolving landscape of medicine development, diversity has become a key driver of innovation. Earlier this year, we sat down with three inspiring leaders from Teva R&D – Heather De Luca, Head of Global Program Leadership; Eric A. Hughes, MD, PhD, Head of Global R&D and Chief Medical Officer; and Sophie Lamle, SVP, Head of Innovative Medicines – to discuss the importance of diversity, innovation, and everything in between. Read the full story here: https://ow.ly/G1UV50UygVK #Tevapharm #ClinicalDevelopment #HealthcareInnovation

As we step into 2025, I’m reflecting on some of our 2024 accomplishments, and one standout moment is hosting the Site Council at our Gentilly and Vitry sites in Paris - an event described by site investigators as a first-of-its-kind initiative from a sponsor. Over two days, 23 site representatives from 9 countries joined Sanofi leaders to exchange ideas, set goals, and discuss key topics like innovation, decentralized trials, patient-centric approaches, and more. This milestone reflects our commitment to strengthening partnerships and shaping the future of clinical trials together. #Collaboration #ClinicalTrials #Innovation #PatientCentricity